BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9656753)

  • 21. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway.
    Steigen SE; Eide TJ
    APMIS; 2006 Mar; 114(3):192-200. PubMed ID: 16643186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
    Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
    Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
    Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
    Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
    Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
    Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
    Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
    Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic resection of clinically suspected gastric stromal tumors.
    Berindoague R; Targarona EM; Feliu X; Artigas V; Balagué C; Aldeano A; Lahoud A; Navines J; Fernandez-Sallent E; Trias M
    Surg Innov; 2006 Dec; 13(4):231-7. PubMed ID: 17227921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of p53 expression in gastrointestinal stromal tumors.
    Yalcinkaya U; Yerci O; Koc EU
    Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors.
    Filiz G; Yalçinkaya O; Gürel S; Yerci O; Memik F
    Hepatogastroenterology; 2007 Mar; 54(74):438-41. PubMed ID: 17523292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery and prognostic factors for gastric stromal tumor.
    Kwon SJ;
    World J Surg; 2001 Mar; 25(3):290-5. PubMed ID: 11343178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors.
    Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Lurje G; Drebber U; Metzger R; Hölscher AH; Schneider PM
    Anticancer Res; 2008; 28(1B):367-72. PubMed ID: 18383871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up.
    Samiian L; Weaver M; Velanovich V
    Am Surg; 2004 Mar; 70(3):187-91; discussion 191-2. PubMed ID: 15055839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal stromal tumors the assessment of malignant potential.
    Nada R; Vaiphei K; Singh R; Wig JD; Gupta NM; Banerjee AK
    Indian J Pathol Microbiol; 2001 Oct; 44(4):393-7. PubMed ID: 12035347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.